Second Annual Leadership Summit for Interventional Cardiologists Held in San Francisco

Second Annual Leadership Summit for Interventional Cardiologists Held in San 
Faculty of Recognized Leadership Experts From Brandeis University,
Yale University, Vocera Communications and The Medicines Company Join
Panel of Leading Interventional Cardiologists From France, the
Netherlands, Australia, China and the United States to Discuss the
Process and Value of Leadership in Interventional Cardiology 
SAN FRANCISCO, CA -- (Marketwired) -- 10/28/13 --  Experts and
panelists from around the world gathered in San Francisco today to
continue a conversation about the development and role of physician
leadership in interventional cardiology. An audience of cardiologists
listened to and contributed to the debate about how doctors can be
better leaders in order to improve both clinical and financial
results of treatment in patients with angina and heart attacks. 
Jon Chilingerian, PhD, Associate Professor of Human Services
Management, Brandeis University, who moderated the program, said,
"Based on our experience with our four-year, dual degree MD-MBA, our
Brandeis Physician Leadership Programs and extant research, we have
learned that physician leaders can make a significant difference in
healthcare delivery outcomes and efficiency in hospitals, including
in interventional cardiology. Our most effective hospitals
successfully integrate educated physician leaders who are prepared to
bring management science closer to clinical operations and medical
decision-making. These physician leaders define a shared clinical
vision and implement medical reforms that challenge assumptions,
behaviors, and systems of authority. Preparing physician leaders
should be a significant ingredient in every nation's health reform." 
Thomas Kolditz, PhD, Retired Brigadier General, Yale School of
Management Professor & Crisis Leadership Expert, added, "High risk
situations are ideal settings to seek, find and develop great
leaders. Interventional cardiology represents a high risk setting
for, at least, the patient. Physicians and their teams need to
practice inspired leadership in this setting." 
Three million patients worldwide and approximately 750,000 in the
United States undergo coronary angioplasty each year. The American
Heart Association recommends teamwork for the procedure -- especially
 heart attacks -- and according to leading experts, saving lives
in the middle of the night demands effective leadership and a strong
predilection for collaboration -- even sometimes a willingness to ask
for help from cardiac surgeons. Furthermore, patient satisfaction and
comfort has also been linked to faster recovery. Emerging data also
link best leadership practices with improved patient mortality and
morbidity rates as well as care efficiency measures in the treatment
of heart attacks. 
"We must make every effort to restore the human connection in
healthcare," said M. Bridget Duffy, MD, Chief Medical Officer of
Vocera Communications, Inc. "Building trust and relationships,
improving communication and designing new models of care that bring
physicians back to the patient bedside will improve both the human
experience and outcomes. This is particularly impactful in high-tech
situations such as interventional cardiology, where patients may
otherwise be reduced to numbers and anonymous images. Our innovation
network is partnering with leading healthcare organizations to build
a new breed of physicians who are equipped to lead the effort to
create a check list of clinical innovations that restore humanity
back to healthcare."  
Clive Meanwell, MD, PhD, Chairman and CEO of The Medicines Company,
said, "Apparently leadership can take us to performance places new
technologies cannot. It is increasingly obvious that in the brave new
world of accountable healthcare, money, equipment and resources will
go to those who can envision and articulate a better future and
achieve goals with others." 
The Second Annual Leadership Summit was produced by The Medicines
Company with guidance from the faculty and panel. The symposium is
part of a global educational platform that aims to assist those
involved in interventional cardiology to acquire data and knowledge,
along with various forms of behavior and competency that can
potentially contribute to saving lives, alleviating suffering and
improving healthcare efficiency in leading hospitals around the
Michael Mitchell 
The Medicines Company
+1 (973) 290-6097 
Press spacebar to pause and continue. Press esc to stop.